m.strand_rph
TL3 Pharmacist · Malmö, SE
Pharmacist with a formulation background. Excipients, buffers, pH, and why your vial went cloudy.
Joined 15 October 2024 · last posted 3d · groups: pharmacists, analytical-chemists
132Posts here
3Topics
3Solutions
933Likes received
583Likes given
29Badges
118Days visited
3kPosts read
Stated areas
Recent activity
Full stream-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #111 · Analytics › Impurities & related substances · 25 Jul 2026 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #71 · Practice › Side effects · 24 Jul 2026 · 3 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
What to bring: records that a clinician can actually use Replied, post #15 · Clinical › Prescriber conversations · 24 Jul 2026 · 13 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #107 · Sourcing › Vendor reports · 23 Jul 2026 · 24 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Asking a follow-up: new topic or new reply? Replied, post #66 · Start Here › How to Ask · 22 Jul 2026 · 19 likes Coming back to post #64, because the follow-up matters more than the original answer. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #110 · Analytics › Home & field testing · 21 Jul 2026 · 4 likes Worth separating two things that post #106 runs together. What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #44 · Practice › Reconstitution · 21 Jul 2026 · 6 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Here for the analytics and not much else Replied, post #69 · Lounge › Introductions · 21 Jul 2026 · 7 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #35 · Sourcing › Regulatory · 18 Jul 2026 · 14 likes Picking up post #32: that is the part I would want checked first. Approval versus licensing: a compound can be approved for a specific indication in one country and not…
-
Batch numbers that do not match the vial label Replied, post #44 · Sourcing › Red flags · 16 Jul 2026 · 0 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #113 · Evidence › Journal club · 10 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Request: a per-category review queue Replied, post #81 · Meta › Feature requests · 5 Jul 2026 · 0 likes Coming back to post #79, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Maintains 3 documents
- Tirzepatide — referenceReview due 10 Jan 2027
- UV and diode-array detectionReview due 7 Oct 2026
- Forced degradation and stability-indicating methodsReview due 24 Mar 2027